Rapid and simple high-performance liquid chromatographic assay for 5'-fluorouracil in plasma for bioavailability studies. 1990

W Jäger, and M J Czejka, and J Schüller, and U Fogl, and E Czejka, and H Lackner
Institute for Pharmaceutical Chemistry, University of Vienna, Austria.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000431 Ethanol A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES. Alcohol, Ethyl,Absolute Alcohol,Grain Alcohol,Alcohol, Absolute,Alcohol, Grain,Ethyl Alcohol
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

W Jäger, and M J Czejka, and J Schüller, and U Fogl, and E Czejka, and H Lackner
September 1991, Journal of chromatography,
W Jäger, and M J Czejka, and J Schüller, and U Fogl, and E Czejka, and H Lackner
March 1996, Journal of chromatography. B, Biomedical applications,
W Jäger, and M J Czejka, and J Schüller, and U Fogl, and E Czejka, and H Lackner
September 1988, Journal of chromatography,
W Jäger, and M J Czejka, and J Schüller, and U Fogl, and E Czejka, and H Lackner
April 1978, Journal of chromatography,
W Jäger, and M J Czejka, and J Schüller, and U Fogl, and E Czejka, and H Lackner
April 1997, Journal of chromatography. B, Biomedical sciences and applications,
W Jäger, and M J Czejka, and J Schüller, and U Fogl, and E Czejka, and H Lackner
January 1995, Journal of chromatography. B, Biomedical applications,
W Jäger, and M J Czejka, and J Schüller, and U Fogl, and E Czejka, and H Lackner
August 2004, Journal of clinical pharmacy and therapeutics,
W Jäger, and M J Czejka, and J Schüller, and U Fogl, and E Czejka, and H Lackner
February 2001, Journal of pharmaceutical and biomedical analysis,
W Jäger, and M J Czejka, and J Schüller, and U Fogl, and E Czejka, and H Lackner
June 2000, Journal of chromatography. B, Biomedical sciences and applications,
W Jäger, and M J Czejka, and J Schüller, and U Fogl, and E Czejka, and H Lackner
January 1996, Journal of chromatography. B, Biomedical applications,
Copied contents to your clipboard!